Ge Li melds WuXi VC with Front­line, cre­at­ing an $800M trans-Pa­cif­ic pow­er­house fund now hunt­ing fresh biotech cap­i­tal

WuXi’s Ge Li is lever­ag­ing up a whole new biotech ven­ture group with am­bi­tious plans to add to the hun­dreds of mil­lions of dol­lars it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.